|
Re: Warrants assuming a PPS of $10.25 CDN...
|
2
|
Resverlogix Corp.
|
Aug 09, 2018 01:42PM
|
|
Re: Promissory Note
|
2
|
Zenith Epigenetics
|
Feb 01, 2021 03:31PM
|
|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
2
|
Resverlogix Corp.
|
Mar 15, 2021 07:42AM
|
|
Re: HOW LONG
|
2
|
Resverlogix Corp.
|
Jul 27, 2022 09:32PM
|
|
Re: Comments on the AGM
|
2
|
Resverlogix Corp.
|
Nov 08, 2019 06:47PM
|
|
Re: Rothschild Engagement – What’s the Strategy?
|
2
|
Resverlogix Corp.
|
Jan 20, 2019 12:47PM
|
|
Re: Expectations for the AGM?
|
2
|
Resverlogix Corp.
|
Dec 07, 2020 04:37PM
|
|
Re: ZHCLF up 290% to $0.16...question
|
2
|
Zenith Epigenetics
|
Dec 15, 2020 10:41AM
|
|
Re: Next question
|
2
|
Resverlogix Corp.
|
Apr 02, 2024 04:53PM
|
|
Re: Pipeline
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 23, 2021 10:26AM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
2
|
Zenith Epigenetics
|
Apr 20, 2022 06:22PM
|
|
Re: Financial Future
|
2
|
Resverlogix Corp.
|
May 19, 2019 07:51PM
|
|
Re: Delivery peptide conjugates of Trastuzumab
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 31, 2018 06:50AM
|
|
Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
2
|
Resverlogix Corp.
|
Aug 25, 2022 02:18PM
|
|
Re: Bioasis announces a joint research collaboration with a leading pharmaceutical company.
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 07, 2019 10:59AM
|
|
Re: The synergy of rosuvastatin (Crestor) with apabetalone
|
2
|
Resverlogix Corp.
|
Oct 07, 2019 11:52AM
|
|
Re: HL Acquires Additional Securities of RVX
|
2
|
Resverlogix Corp.
|
May 22, 2021 09:03AM
|
|
Retire at 55 and live to 80+.
|
2
|
Resverlogix Corp.
|
Jan 07, 2019 11:17AM
|
|
Re: Zenith and Pfizer collaboration news
|
2
|
Zenith Epigenetics
|
Nov 20, 2018 09:14AM
|
|
Re: BETonMACE Enrollment
|
2
|
Resverlogix Corp.
|
Mar 25, 2017 02:27PM
|
